Precision Business Insights


Research Reports

Databank $ 3,000.00
Single User $ 4,400.00
Multiple User $ 6,600.00
Corporate User $ 8,900.00
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors


    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets


    We provide impeccable research reports in quick turnaround time

Melanoma Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024


Available formats:    


Global Melanoma Diagnostics Market


Type of Condition (Superficial Spreading Melanoma, Lentigo Maligna Melanoma, Nodular Melanoma,Acral Lentiginous Melanoma), Type of Test (Dermatoscopy, Optical Coherence Tomography, Multispectral Imaging, Non-invasive Genome Detection, Electrical impedance spectroscopy (EIS), Fiber Diffraction, Tissue Elastography, Thermal Imaging, Positron emission tomography (PET), MRI –Scan, CT-Scan, Sentinel Lymph Node Biopsy), End user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023


Global Melanoma Diagnostics market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2017 to 2023.


Market Outline: Melanoma Diagnostics Market

Melanoma is the more serious type of cancer which develops in cells of skin called melanocytes that produce melanin. Melanoma not only affects skin but it also affects eyes and rarely, affects internal organs such as the intestine. The exact cause of melanoma is not clearly known, but the exposure of skin to UV radiation or tanning lumps and beds increases risk of developing melanoma.


Market Dynamics: Melanoma Diagnostics Market

Melanoma Diagnostics market is primarily driven by the increase in number of people suffering from melanoma coupled with the advancements and approvals of new technologies for the diagnosis of melanoma. In addition, growing number of developments, current pipeline tests and biomarkers and their expected approvals during the forecast period projected to boost the Melanoma Diagnostics market over the forecast period. Furthermore, increase in government support and R&D activities to fight against cancer coupled with various initiatives by government and non-government organizations expected to bolster the market growth over the forecast period. However, high cost associated with the diagnosis process, regulatory constraints may hinder the growth of Melanoma Diagnostics market globally.


Market Scope: Melanoma Diagnostics Market

Melanoma Diagnostics market is segmented based on the type of condition, type of test, end user and geographical regions

Based on the type of condition, the market is segmented into the following:

  • Superficial Spreading Melanoma
  • Lentigo Maligna Melanoma
  • Nodular Melanoma
  • Acral Lentiginous Melanoma

Based on the type of test, the market is segmented into the following:

  • Dermatoscopy
  • Optical Coherence Tomography
  • Multispectral Imaging
  • Non-invasive Genome Detection
  • Electrical impedance spectroscopy (EIS)
  • Fiber Diffraction
  • Tissue Elastography
  • Thermal Imaging
  • Positron emission tomography (PET)
  • MRI –Scan
  • CT-Scan
  • Sentinel Lymph Node Biopsy

Based on the end user, the market is segmented into the following:

  • Diagnostic Centers
  • Hospitals
  • Ambulatory Surgical Centers

Based on the geographical regions, the market is segmented into the following:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa


Market Summary: Melanoma Diagnostics Market

The upsurge in the global melanoma prevalence rates and pipeline drugs for the treatment of melanoma projected to boost the global Melanoma Diagnostics market at significant rates over the forecast period. According to World Health Organization (WHO), there is continuous increase in global prevalence of melanoma worldwide and estimated to be 132,000 melanoma skin cancers occurs every year. Companies in marketplace are focused on development of the new  biomarker assays and tests for the diagnosis of melanoma. Furthermore, companies also focus on collaborations and acquisitions to develop the new drug treatments and expanding their portfolio in Melanoma Diagnostics market. For instance, in January 2018, Skyline Dx INKS entered into a joint development agreement with mayo clinic to develop diagnostic tests for melanoma


Regional Analysis:  Melanoma Diagnostics Market

Geographically, global Melanoma Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America Melanoma Diagnostics market expected to grow at significant rates due to the high prevalence of the disease in the region. According to American Cancer Society, the rates of melanoma are raising from past 30 years and about 91,270 new melanomas will be diagnosed in 2018. In addition, favourable reimbursement policies in the region coupled with the increase in disposable income are expected to boost the market share of the region over the forecast period. Europe Melanoma Diagnostics market projected to grow at notable rates owing to the factors such as growing prevalence of melanoma, presence of key market players in the region and increase in R&D towards the development of new treatments for cancer backed with growing government funding. Asia Pacific Melanoma Diagnostics market projected to have the lucrative growth opportunity due to growing healthcare expenditure by the population and increase in R&D investments by the companies and government in the region.


Notable Market Developments:  Melanoma Diagnostics Market

  • In January 2014, Michelson diagnostics, UK based medical device company focused on multi beam optical coherence tomography technology and received award of €2.26 million Framework 7 grant to a consortium of seven partners, towards the cost of project targeting malignant with OCT imaging.


Competition Assessment: Melanoma Diagnostics Market

Some of the players in the global Melanoma Diagnostics market include:

  • Abbott Laboratories (U.S)
  • Ariad Pharmaceuticals, Inc. (U.S)
  • Pfizer (U.S)
  • Sanofi S.A (France)
  • Novartis (Switzerland)
  • Merck & Co., Inc. (U.S)
  • Becton, Dickinson & Co. (U.S)
  • Eli Lilly and Co (U.S)
  • Siemens Healthcare Inc. (Germany)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • GlaxoSmithKline Plc., etc. (UK)
  • AstraZeneca plc  (UK)
  • Bristol-Myers Squibb (U.S)


Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Abbott Laboratories (U.S)
  • Ariad Pharmaceuticals, Inc. (U.S)
  • Pfizer (U.S)
  • Sanofi S.A (France)
  • Novartis (Switzerland)
  • Merck & Co., Inc. (U.S)
  • Becton, Dickinson & Co. (U.S)
  • Eli Lilly and Co (U.S)
  • Siemens Healthcare Inc. (Germany)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • GlaxoSmithKline Plc., etc. (UK)
  • AstraZeneca plc  (UK)
  • Bristol-Myers Squibb (U.S)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements


Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553